EP3861347
BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.10.2019EP published:
21.12.2022EP application number:
19790312.3
EPO information:
European Patent Register
Max expiry date:
1.10.2039
Title in English:
BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUSLanguage of the patent:
English
Timeline
Today
2.10.2019EP application
21.12.2022EP Publication
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP
Inventor
Name:
FUNAHASHI YasuhiroAddress:
Tsukuba-shi, Ibaraki 300-2635, JP
Name:
MINOSHIMA YukinoriAddress:
Tsukuba-shi, Ibaraki 300-2635, JP
Name:
KANEKIYO MichioAddress:
Woodcliff Lake,New Jersey 07677, US
Name:
MATSUKI MasahiroAddress:
Tsukuba-shi, Ibaraki 300-2635, JP
Name:
ADACHI YusukeAddress:
Tsukuba-shi, Ibaraki 300-2635, JP
Name:
KODAMA KotaroAddress:
Tsukuba-shi, Ibaraki 300-2635, JP
Priority
Number:
201862741861 PDate:
5.10.2018Country:
US
Classification
Categories:
G01N 33/574, G01N 33/68, G01N 33/74